Table 3:
Radiologic follow-up results
| Overall | Aspirin+Clopidogrel Group | Aspirin+Ticagrelor Group | P Value | |
|---|---|---|---|---|
| Follow-up (%) | 211/233 (90.6) | 126/140 (90.0) | 85/93 (91.4) | |
| Period (median) (IQR) (mo) | 25.1 | 37.0 (25.0–48.75) | 13.8 (7.5–23.1) | <.001 |
| Aneurysm occlusiona (%) | .552 | |||
| I | 154 (73.0) | 92 (73.0) | 62 (72.9) | |
| II | 27 (12.8) | 14 (11.1) | 13 (15.3) | |
| III | 30 (14.2) | 20 (15.9) | 10 (11.8) | |
| In-stent stenosis | .603 | |||
| <50% | 188 (89.1) | 114 (90.5) | 74 (87.1) | |
| >50% | 6 (2.8) | 2 (1.6) | 4 (4.7) | |
| Unknownb | 17 (8.1) | 10 (7.9) | 7 (8.2) | |
| Retreatment | 16 (6.8) | 10 (7.0) | 6 (6.5) | >.999 |
a
Raymond-Roy Occlusion Classification.
b
Stented vessel could not be evaluated due to a marker band effect.